Margaret Rosenfeld

Adjunct Professor, Epidemiology
Professor, Pediatrics - Pulmonary and Sleep Medicine



MD Harvard Medical School, 1988
MPH Epidemiology, University of Washington, 1995




Margaret Rosenfeld is Associate Vice Chair for Clinical Research and Professor of Pediatrics and Adjunct Professor of Epidemiology at the University of Washington. Her research program focuses on the assessment and treatment of chronic lung diseases in children, including multicenter clinical trials and observational studies in children with cystic fibrosis and primary ciliary dyskinesia. She is the physician liaison to the Department of Health for CF newborn screening. She also conducts research on mobile health tools as clinical trial endpoints and for diagnosis and treatment of respiratory diseases in low resource settings.

Recent Publications (PubMed)

A Phase 3, Open-Label Study of Lumacaftor/Ivacaftor in Children 1 to Less Than 2 Years of Age With Cystic Fibrosis Homozygous for F508del-CFTR.
(2022 Jun 30)
Am J Respir Crit Care Med
Rayment JH, Asfour F, Rosenfeld M, Higgins M, Liu L, Mascia M, Paz-Diaz H, Tian S, Zahigian R, McColley SA, VX16-809-122 Study Group.

COMBATing airway inflammation in infants with cystic fibrosis.
(2022 Jun 2)
Lancet Respir Med
Rosenfeld M, Ratjen F

Association of Neonatal Hospital Length of Stay with Lung Function in Primary Ciliary Dyskinesia.
(2022 Jun 3)
Ann Am Thorac Soc
Wee WB, Leigh MW, Davis SD, Rosenfeld M, Sullivan KM, Sawras MG, Ferkol TW, Knowles MR, Milla C, Sagel SD, Zariwala MA, Pullenayegum E, Dell SD

Accounting for population structure in genetic studies of cystic fibrosis.
(2022 Jul 14)
HGG Adv 3(3): 100117
Kingston H, Stilp AM, Gordon W, Broome J, Gogarten SM, Ling H, Barnard J, Dugan-Perez S, Ellinor PT, Gabriel S, Germer S, Gibbs RA, Gupta N, Rice K, Smith AV, Zody MC, Cystic Fibrosis Genome Project., NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium., Blackman SM, Cutting G, Knowles MR, Zhou YH, Rosenfeld M, Gibson RL, Bamshad M, Fohner A, Blue EE

Application of gap time analysis with flexible hazards to pulmonary exacerbations in the EPIC observational study.
(2022 Apr 18)
Biom J
Rice JD, Johnson RL, Juarez-Colunga E, Zemanick ET, Rosenfeld M, Wagner BD

Show complete publication list

In the News

No news articles at this time.